🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

CLK2

MOLECULAR TARGET

CDC like kinase 2

UniProt: P49760NCBI Gene: 119652 compounds

CLK2 (CDC like kinase 2) is targeted by 52 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CLK2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1epigalocatechin gallate5.40220
2seliciclib4.91135
3alvocidib4.5291
4ruxolitinib4.2368
5pi 1034.1764
6bosutinib4.0858
7bi 25364.0154
8midostaurin3.8546
9brigatinib3.8144
10silmitasertib3.7843
11abemaciclib3.6638
12nintedanib3.6136
13pelitinib3.5032
14bms 3870323.4731
15tae 6843.4330
16fedratinib3.4029
17mln 80543.3327
18at 75193.3327
19tandutinib3.2224
20sp 6001253.2224
21alectinib3.1823
22dovitinib3.0921
23jnj 77066213.0921
24lestaurtinib3.0420
25ruboxistaurin2.9418
26r 4062.8316
27k 252a2.8316
28sotrastaurin2.7715
29pha 6657522.7114
30plx 47202.7114
31kw 24492.6413
32gsk 6906932.6413
33mli 22.6413
34ast 4872.5612
35su 0148132.208
36leucettamine b2.208
37cyc 1162.087
38enzastaurin2.087
39tg100 1152.087
40rg 5472.087
41amg 9002.087
42gsk 10596151.956
43sra 7371.956
44sel 120 free base1.956
45demethylbellidifolin1.956
46t3 clk1.795
47lorecivivint1.795
48Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is1.614
49sp6001251.393
50egcg0.691

Showing top 50 of 52 compounds. Use the BiohacksAI search to explore all CLK2 modulators.

About CLK2 as a Drug Target

CLK2 (CDC like kinase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 52 compounds with documented CLK2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CLK2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.